Aurélie Jeandron (People)
https://www.swisstph.ch/en/staff/profile/people/aurelie-jeandron
operational challenges posed by resource-limited settings. She recently broadened her expertise to malaria modelling, after having focused on water, sanitation and hygiene and environmental health. Education
Sophie Diarra (People)
https://www.swisstph.ch/en/staff/profile/people/sophie-diarra
of the Health Interventions Unit at Swiss TPH, Sophie is currently investigating key factors in malaria control, applying a socio-epidemiological approach in Papua New Guinea . Her key interests lie in
Christian Selinger (People)
https://www.swisstph.ch/en/staff/profile/people/christian-selinger
in pathogens and diseases affecting humans such as HIV, Influenza, Polio, HPV, Coronaviruses and Malaria.
Aita Signorell (People)
https://www.swisstph.ch/en/staff/profile/people/aita-signorell
circumstances in resource limited settings and designed for poverty-related diseases like tuberculosis, malaria and sleeping sickness. Dr. Signorell’s primary interest lies in the field of community-centered medicines
Health Impact Assessment (Page)
https://www.swisstph.ch/en/about/eph/ecosystem-health-sciences/health-impact-assessment
Assessments Genetically modified mosquitoes have great potential for malaria control. Any future use of gene drive mosquitoes for malaria control will require many elements, including policy, regulatory approvals [...] ions. On behalf of Target Malaria, Swiss TPH conducted a SEA scoping study on the potential use of Anopheles mosquitoes containing a gene drive construct to suppress malaria vector mosquitoes. Read more
Declining burden of <em>Plasmodium vivax</em> in a population in northwestern Thailand from 1995 to 2016 before comprehensive primaquine prescription... (Publications)
and artemisinin-based therapy, species-specific diagnostics, and bed net usage all of which reduce malaria transmission but not P. vivax relapse. In the absence of widespread primaquine use for radical cure
Ensuring transmission through dynamic host environments: host-pathogen interactions in <em>Plasmodium </em>sexual development (Publications)
A renewed global commitment to malaria elimination lends urgency to understanding the biology of Plasmodium transmission stages. Recent progress toward uncovering the mechanisms underlying Plasmodium
Vector-borne diseases in humans and animals: activities of the Swiss Tropical Institut and risks for Switzerland (Publications)
This overview presents the Swiss Tropical Institute's (STI) activities on vector-borne diseases (malaria, trypanosomosis, and leishmaniosis in humans and tick-borne diseases in livestock), describes the
Repurposing know-how for drug development: case studies from the Swiss Tropical and Public Health Institute (Publications)
of neglected tropical diseases and other infectious diseases of poverty, such as schistosomiasis, malaria and human African trypanosomiasis.
The pharmacokinetics and drug-drug interactions of ivermectin in <em>Aedes aegypti</em> mosquitoes (Publications)
Mosquitoes are vectors of major diseases such as dengue fever and malaria. Mass drug administration of endectocides to humans and livestock is a promising complementary approach to current insecticide-based
